Essential metabolites of Mycobacterium tuberculosis and their mimics
An organism requires a range of biomolecules for its growth. By definition, these are
essential molecules which constitute the basic metabolic requirements of an organism. A …
essential molecules which constitute the basic metabolic requirements of an organism. A …
Experimental models used to study human tuberculosis
R O'Toole - Advances in applied microbiology, 2010 - Elsevier
Mycobacterium tuberculosis causes more deaths in humans than any other bacterial
pathogen. The most recent data from the World Health Organization reveal that over 9 …
pathogen. The most recent data from the World Health Organization reveal that over 9 …
High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium …
M Silva-Miranda, E Ekaza, A Breiman… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Tuberculosis remains a major health problem due to the emergence of drug-resistant strains
of Mycobacterium tuberculosis. Some models have provided valuable information about …
of Mycobacterium tuberculosis. Some models have provided valuable information about …
Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System
C Rodrigues, J Jani, S Shenai… - … of tuberculosis and …, 2008 - ingentaconnect.com
OBJECTIVE: To establish the critical test concentrations for seven second-line anti-
tuberculosis drugs in the Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 TB system …
tuberculosis drugs in the Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 TB system …
Using animal models to develop new treatments for tuberculosis
E Nuermberger - Seminars in respiratory and critical care …, 2008 - thieme-connect.com
Animal models have an important role in the preclinical evaluation of new antituberculosis
drug candidates. Although it does not recapitulate the clinicopathological manifestations of …
drug candidates. Although it does not recapitulate the clinicopathological manifestations of …
Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance
Despite the low expensive and effective four-drug treatment regimen (isoniazid, rifampicin,
pyrazinamide and ethambutol) was introduced 40 years ago, TB continues to cause …
pyrazinamide and ethambutol) was introduced 40 years ago, TB continues to cause …
Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems
TS Huang, HZ Tu, SSJ Lee… - Annals of Clinical & …, 2002 - Assoc Clin Scientists
The reliability of the Mycobacteria Growth Indicator Tube (MGIT) 960 system for rapid
antimicrobial susceptibility testing (AST) of Mycobacterium tuberculosis was evaluated. Forty …
antimicrobial susceptibility testing (AST) of Mycobacterium tuberculosis was evaluated. Forty …
[HTML][HTML] In vitro mycobacterial growth inhibition assays: a tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
Tuberculosis (TB) continues to pose a serious global health threat, and the current vaccine,
BCG, has variable efficacy. However, the development of a more effective vaccine is …
BCG, has variable efficacy. However, the development of a more effective vaccine is …
Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay
JD Guzman, D Evangelopoulos, A Gupta, K Birchall… - BMJ open, 2013 - bmjopen.bmj.com
Objectives Lead antituberculosis (anti-TB) molecules with novel mechanisms of action are
urgently required to fuel the anti-TB drug discovery pipeline. The aim of this study was to …
urgently required to fuel the anti-TB drug discovery pipeline. The aim of this study was to …
[HTML][HTML] Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
L Marsay, M Matsumiya, R Tanner, H Poyntz… - Tuberculosis, 2013 - Elsevier
Development of an improved vaccine against tuberculosis (TB) is hindered by the lack of a
surrogate of protection. Efficacy of new TB vaccines in humans can only be evaluated by …
surrogate of protection. Efficacy of new TB vaccines in humans can only be evaluated by …